資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/27862
|
標題: | In Vitro Efficacies and Resistance Profiles of Rifampin-Based Combination Regimens for Biofilm-Embedded Methicillin-Resistant Staphylococcus aureus |
作者: | Tang, Hung-Jen Chen, Chi-Chung Cheng, Kuo-Chen Wu, Kuan-Ying Lin, Yi-Chung Zhang, Chun-Cheng Weng, Tzu-Chieh Yu, Wen-Liang Chiu, Yu-Hsin Toh, Han-Siong Chiang, Shyh-Ren Su, Bo An Ko, Wen-Chien Chuang, Yin-Ching |
貢獻者: | Chi Mei Med Ctr, Dept Med Chi Mei Med Ctr, Dept Med Res Natl Cheng Kung Univ, Dept Med, Med Coll & Hosp Natl Cheng Kung Univ, Inst Biotechnol, Med Coll & Hosp Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr |
關鍵字: | Field Gel-Electrophoresis Antimicrobial Agents Fusidic Acid Infections Tigecycline |
日期: | 2013-11 |
上傳時間: | 2014-05-26 10:46:42 (UTC+8) |
出版者: | Amer Soc Microbiology |
摘要: | To compare the in vitro antibacterial efficacies and resistance profiles of rifampin-based combinations against methicillin-resistant Staphylococcus aureus (MRSA) in a biofilm model, the antibacterial activities of vancomycin, teicoplanin, daptomycin, minocycline, linezolid, fusidic acid, fosfomycin, and tigecycline alone or in combination with rifampin against biofilm-embedded MRSA were measured. The rifampin-resistant mutation frequencies were evaluated. Of the rifampin-based combinations, rifampin enhances the antibacterial activities of and even synergizes with fusidic acid, tigecycline, and, to a lesser extent, linezolid, fosfomycin, and minocycline against biofilm-embedded MRSA. Such combinations with weaker rifampin resistance induction activities may provide a therapeutic advantage in MRSA biofilm-related infections. |
link: | http://dx.doi.org/10.1128/AAC.01236-13 |
關聯: | Antimicrobial Agents And Chemotherapy, v.57 n.11 pp.5717-5720 |
顯示於類別: | [保健營養系(所) ] 期刊論文
|
文件中的檔案:
檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
10.1128_AAC.01236-13.pdf | | 375Kb | Adobe PDF | 311 | 檢視/開啟 | index.html | | 0Kb | HTML | 1762 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|